Informationen:
Fehler:
ID
36864
Beschreibung
Fairly Brief Androgen Suppression and Stereotactic Radiotherapy for High Risk Prostate Cancer - Protocol 2; ODM derived from: https://clinicaltrials.gov/show/NCT02229734
Link
https://clinicaltrials.gov/show/NCT02229734
Stichworte
Versionen (1)
- 17.06.19 17.06.19 -
Rechteinhaber
See clinicaltrials.gov
Hochgeladen am
17. Juni 2019
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Prostate Cancer NCT02229734
Eligibility Prostate Cancer NCT02229734
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Prostate Cancer NCT02229734
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
High risk Prostate carcinoma
Item
high risk prostate cancer
boolean
C0332167 (UMLS CUI [1,1])
C0600139 (UMLS CUI [1,2])
C0600139 (UMLS CUI [1,2])
Multidisciplinary assessment Radiation Oncologist Urologist
Item
has had multidisciplinary consultation with radiation oncologist and urologist
boolean
C0729737 (UMLS CUI [1,1])
C1514693 (UMLS CUI [1,2])
C0260314 (UMLS CUI [1,3])
C1514693 (UMLS CUI [1,2])
C0260314 (UMLS CUI [1,3])
Age | Standard therapy Refused
Item
age >70 or refuses standard treatment
boolean
C0001779 (UMLS CUI [1])
C2936643 (UMLS CUI [2,1])
C1705116 (UMLS CUI [2,2])
C2936643 (UMLS CUI [2,1])
C1705116 (UMLS CUI [2,2])
Disease Extraprostatic Absent Bone scan | Disease Extraprostatic Absent CT scan
Item
no evidence of extra-prostatic disease on screening bone scan and ct scan (non-contrast ct used for ct simulation acceptable)
boolean
C0012634 (UMLS CUI [1,1])
C1517078 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
C0203668 (UMLS CUI [1,4])
C0012634 (UMLS CUI [2,1])
C1517078 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
C0040405 (UMLS CUI [2,4])
C1517078 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
C0203668 (UMLS CUI [1,4])
C0012634 (UMLS CUI [2,1])
C1517078 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
C0040405 (UMLS CUI [2,4])
Informed Consent
Item
signed written and voluntary informed consent provided.
boolean
C0021430 (UMLS CUI [1])
Protocol Compliance
Item
patients must be willing and able to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures
boolean
C0525058 (UMLS CUI [1])
Inclusion criteria failed
Item
patients not meeting the eligibility criteria
boolean
C1512693 (UMLS CUI [1,1])
C0231175 (UMLS CUI [1,2])
C0231175 (UMLS CUI [1,2])
Radiotherapy to pelvis | Brachytherapy
Item
prior pelvic radiotherapy or brachytherapy
boolean
C1536155 (UMLS CUI [1])
C0006098 (UMLS CUI [2])
C0006098 (UMLS CUI [2])
Use of anticoagulation | Heparin, Low-Molecular-Weight | Coumadin
Item
use of anti-coagulation (low molecular weight heparin or coumadin)
boolean
C0449867 (UMLS CUI [1])
C0019139 (UMLS CUI [2])
C0699129 (UMLS CUI [3])
C0019139 (UMLS CUI [2])
C0699129 (UMLS CUI [3])
Inflammatory Bowel Disease | Crohn Disease | Diverticulitis | Collagen-vascular disease | Exception Rheumatoid Arthritis
Item
history of inflammatory bowel disease, crohn's disease, diverticulitis or collagen vascular disease (other than rheumatoid arthritis)
boolean
C0021390 (UMLS CUI [1])
C0010346 (UMLS CUI [2])
C0012813 (UMLS CUI [3])
C0262428 (UMLS CUI [4])
C1705847 (UMLS CUI [5,1])
C0003873 (UMLS CUI [5,2])
C0010346 (UMLS CUI [2])
C0012813 (UMLS CUI [3])
C0262428 (UMLS CUI [4])
C1705847 (UMLS CUI [5,1])
C0003873 (UMLS CUI [5,2])
Prior Therapy Malignant Neoplasms | Exception Basal cell carcinoma | Exception Squamous cell carcinoma of skin
Item
previous treatment for malignancy (other than basal or squamous cell skin cancer) within 3 years of prostate cancer diagnosis
boolean
C1514463 (UMLS CUI [1,1])
C0006826 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0007117 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0553723 (UMLS CUI [3,2])
C0006826 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0007117 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0553723 (UMLS CUI [3,2])
Antiandrogen therapy
Item
patients on androgen deprivation therapy > 2 months prior to study enrolment
boolean
C0279492 (UMLS CUI [1])